- #1
- 2,486
- 9,720
Lancet has a report of a vaccine for the Ebola virus.
Seems like the vaccine should be very helpful in future outbreaks. However, it's efficacy will rely on the ability of government and public health officials to efficiently distribute the vaccine in future outbreaks, which is not always so easy in the third-world countries where Ebola outbreaks occur.In a scientific triumph that will change the way the world fights a terrifying killer, an experimental Ebola vaccine tested on humans in the waning days of the West African epidemic has been shown to provide 100 percent protection against the lethal disease.
The vaccine has not yet been approved by any regulatory authority, but it is considered so effective that an emergency stockpile of 300,000 doses has already been created for use should an outbreak flare up again.
An ideal vaccine would protect against all Ebola strains and Marburg. However, Dr. Kieny said, it may not be possible to make a shot effective against several strains if it is t based on the VSV spine because VSV triggers a lot of side effects.
Risks that are acceptable in the midst of a deadly epidemic are not acceptable in a preventive vaccine given to healthy children and adults, several experts noted.
The Ebola vaccine is a type of vaccine that is designed to protect individuals from contracting the Ebola virus. It works by introducing a weakened or inactive form of the virus into the body, triggering the immune system to build up immunity against it.
The Ebola vaccine has been shown to be effective in preventing the Ebola virus from replicating in the body. It does this by stimulating the body's immune response and producing antibodies that can recognize and neutralize the virus.
The Ebola vaccine has been extensively tested and has been found to be safe for use in humans. However, like any vaccine or medication, there can be potential side effects, although they are usually mild and temporary.
According to clinical trials, the Ebola vaccine has been found to be highly effective in preventing the Ebola virus. In a large-scale study, it was shown to be 100% effective in protecting individuals from contracting the virus.
The Ebola vaccine has been approved for use in some countries and is currently being used in areas where the virus is prevalent. However, it is still undergoing further testing and development before it can be made available for widespread use.